• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVES Back to Search Results
Model Number PVS23
Device Problems Perivalvular Leak (1457); Device Dislodged or Dislocated (2923)
Patient Problems Aortic Insufficiency (1715); Heart Failure (2206)
Event Date 12/09/2016
Event Type  Injury  
Manufacturer Narrative
Device not explanted.
 
Event Description
The manufacturer was informed on this event through the recent publication 'acute dislocation of a perceval valve treated with tavi valve-in-valve: a literature review and case report' by julieta d morales-portano et al.A (b)(6) male with a history of hypertension, presented with severe dyspnea (nyha-iii); severe aortic stenosis was revealed by transthoracic echocardiography (tte); surgical procedure with a perceval valve size m (pvs23) was made without any complications (mean gradient 12 mmhg.The patient was transferred to the intensive care unit, but twenty-four hours after the procedure, the patient presented acute heart failure.The tee revealed a severe paravalvular leak, then fluoroscopy confirmed the dislocated and dysfunctional perceval valve.An emergency transcatheter aortic valve-in-valve (tavi-viv) procedure with a corevalve 29 mm was performed to correct the dislocated valve.The clinical status of the patient improved rapidly, and the patient was discharged without any complications one week after the procedure.
 
Manufacturer Narrative
The manufacturer received the serial number of the device involved in this event.
 
Event Description
The implant of the perceval was on (b)(6) 2016, and the date of tavi was (b)(6) 2016.The remainder of the information previously submitted remains unchanged.
 
Manufacturer Narrative
Sections changed: b3, b4, b5, d6, g4, g7, h1, h2, h6.A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.Since the device was not explanted (viv performed), no further device investigation is possible at this time.Based on the available information, and given that no analysis of the device could be performed, it is not possible to draw a definitive conclusion for the reported event.However, based on the document review performed no manufacturing deficits were identified.As commented in the paper, 'although the surgeon was familiarized with the surgical technique, we cannot assure whether or not the cause of the dislocation could be related to the valve undersizing or to a high positioning of the prosthesis'.Based on this, a possible root cause can be traced to an unintended procedural error (malpositioning/mis-sizing).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVES
Manufacturer (Section D)
LIVANOVA CANADA CORP
5005 north fraser way
burnaby, british columbia
MDR Report Key9211730
MDR Text Key163128127
Report Number3005687633-2019-00236
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Type of Report Initial,Followup,Followup
Report Date 02/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/19/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/01/2020
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received01/29/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age76 YR
-
-